{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:58:10Z","timestamp":1791226690272,"version":"4.1.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T00:00:00Z","timestamp":1422403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0117255","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T18:50:18Z","timestamp":1422471018000},"page":"e0117255","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice"],"prefix":"10.1371","volume":"10","author":[{"given":"Polyxeni T.","family":"Mantani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontus","family":"Dun\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnar","family":"Alm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Ljungcrantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"S\u00f6derberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Sundius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Bj\u00f6rkbacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla Nordin","family":"Fredrikson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,1,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","article-title":"IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo","volume":"15","author":"MM Fort","year":"2001","journal-title":"Immunity"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1084\/jem.20051496","article-title":"Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract","volume":"203","author":"AM Owyang","year":"2006","journal-title":"J Exp Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1084\/jem.20061738","article-title":"IL-25 regulates Th17 function in autoimmune inflammation","volume":"204","author":"MA Kleinschek","year":"2007","journal-title":"J Exp Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2337\/db08-1113","article-title":"Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice","volume":"58","author":"JA Emamaullee","year":"2009","journal-title":"Diabetes"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1189\/jlb.0311160","article-title":"Nuocytes: expanding the innate cell repertoire in type-2 immunity","volume":"90","author":"JL Barlow","year":"2011","journal-title":"J Leukoc Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nri3349","article-title":"Innate lymphoid cells\u2014how did we miss them?","volume":"13","author":"JA Walker","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1073\/pnas.1003988107","article-title":"Systemically dispersed innate IL-13-expressing cells in type 2 immunity","volume":"107","author":"AE Price","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nature08900","article-title":"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity","volume":"464","author":"DR Neill","year":"2010","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells","volume":"463","author":"K Moro","year":"2010","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20121964","article-title":"Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages","volume":"210","author":"AB Molofsky","year":"2013","journal-title":"J Exp Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1161\/ATVBAHA.113.302571","article-title":"Helix-Loop-Helix Factor Inhibitor of Differentiation 3 Regulates Interleukin-5 Expression and B-1a B-Cell Proliferation","volume":"33","author":"HM Perry","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2901","article-title":"The double life of a B-1 cell: self-reactivity selects for protective effector functions","volume":"11","author":"N Baumgarth","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1172\/JCI36800","article-title":"Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans","volume":"119","author":"MY Chou","year":"2009","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCRESAHA.111.248542","article-title":"B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions","volume":"109","author":"T Kyaw","year":"2011","journal-title":"Circ Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tcm.2012.06.011","article-title":"Protective role of natural IgM-producing B1a cells in atherosclerosis","volume":"22","author":"T Kyaw","year":"2012","journal-title":"Trends Cardiovasc Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"GK Hansson","year":"2011","journal-title":"Nat Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1172\/JCI63108","article-title":"Adaptive immunity in atherogenesis: new insights and therapeutic approaches","volume":"123","author":"AH Lichtman","year":"2013","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1073\/pnas.92.3.821","article-title":"Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis","volume":"92","author":"W Palinski","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.ATV.16.8.1074","article-title":"Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits","volume":"16","author":"S Ameli","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1073\/pnas.0409015102","article-title":"T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses","volume":"102","author":"C Buono","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.ATV.0000059419.11002.6E","article-title":"Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse","volume":"23","author":"C Buono","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"H Ait-Oufella","year":"2006","journal-title":"Nat Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tcm.2007.03.001","article-title":"Regulatory T-cell immunity in atherosclerosis","volume":"17","author":"Z Mallat","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvn120","article-title":"Cytokines and atherosclerosis: a comprehensive review of studies in mice","volume":"79","author":"R Kleemann","year":"2008","journal-title":"Cardiovasc Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1172\/JCI200420479","article-title":"IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis","volume":"114","author":"CJ Binder","year":"2004","journal-title":"J Clin Invest"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"AM Miller","year":"2008","journal-title":"J Exp Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/HJR.0b013e32832a05df","article-title":"Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden","volume":"16","author":"H Gronlund","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature12526","article-title":"Type 2 innate lymphoid cells control eosinophil homeostasis","volume":"502","author":"JC Nussbaum","year":"2013","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cytogfr.2010.05.001","article-title":"Interleukin-25: a two-edged sword in the control of immune-inflammatory responses","volume":"21","author":"G Monteleone","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jacc.2006.11.054","article-title":"Phosphorylcholine-targeting immunization reduces atherosclerosis","volume":"50","author":"G Caligiuri","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jacc.2008.06.047","article-title":"Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis","volume":"52","author":"M Sampi","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/path.2667","article-title":"Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques","volume":"220","author":"OJ de Boer","year":"2010","journal-title":"J Pathol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00000441-200201000-00002","article-title":"Mouse models of atherosclerosis","volume":"323","author":"A Daugherty","year":"2002","journal-title":"Am J Med Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"L1238","DOI":"10.1152\/ajplung.00301.2005","article-title":"TNF-alpha and IFN-gamma inversely modulate expression of the IL-17E receptor in airway smooth muscle cells","volume":"290","author":"S Lajoie-Kadoch","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.4049\/jimmunol.1200708","article-title":"Interruption of the OX40-OX40 Ligand Pathway in LDL Receptor-Deficient Mice Causes Regression of Atherosclerosis","volume":"191","author":"AC Foks","year":"2013","journal-title":"J Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0117255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T12:08:23Z","timestamp":1598702903000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0117255"}},"subtitle":[],"editor":[{"given":"Karin","family":"Jandeleit-Dahm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,1,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,1,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0117255","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,28]]}}}